Clinical Trial Update: IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on an IL-10 stratifying tool intended to guide antibiotic selection for MRSA bacteremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia

Snippet

Sponsor: Sharp HealthCare | Conditions: Bacteremia | Phase 4 | Status: COMPLETED